Dr Peter Carter, President to Companies & General Secretary of the Royal College of the Nursing (RCN), said:

“Sisters are often first point of the contact when work with sexual questions of health, and this year subject for Sexual Week of Health, She - My Right! provides the possibility to train on how to provide the specific advice and information on sexual health for people with study of disability.

” It is Important healthcare professionals, and indeed public, understand the problems and sensitivity to sexuality and sexual health, even more so that for people with study of disability who it is necessary additional support.

” RCN Supports Planning to Families to Assotiations of the measures to raise privity about issue of sexual health for people with study of disability and promote healthcare professional, including to lead in promoting this campaigns in society.

“We urge the Government to promote be invested on formation and preparing the possibilities for in the field of and for that solving lay on sexual health. (Read ‘RCN SUPPORTS Sexual Week of Health 4 - 10 August’…)

Pfizer’s erectile Medication in dysfunctions Viagra can perfect the sexual function for some womans, who takes the of the facility, according to analysis published In ambience in Journal of the American Medical Assotiation, messages Sun Baltimore Kohn, Sun Baltimore. According to AP/Denver Post, the preceding analysis has found that more, than 50% patient, which takes the side effects an facilities of the development, which includes the shortened sexual function Johnson, AP/Denver Post.

For analysis, George Nurnberg, University New School Medicine psychiatrist Mexico, and colleagues divided 98 womens, which took serotonin sm-uptake inhibitors in two groups, that which took Viagra and that which took Sun Baltimore. (Read ‘Viagra Can Perfect Sexual Function For Womans, Analysis Turns out to be’…)

Recently, the phenomena known as the PSA bounce has been recognized as occurring in at least 30% of patients postimplant. Critz et al first reported on this event in 2000 where 273 of 779 men experienced a transient increase in PSA a median 18-months postimplant. The median bounce was 0.4 ng/mL and 92% of bounces occurred within 36 months.
The group from the Seattle Prostate Institute made similar observations later that year in 591 patients treated between 1988 and 1993. Thirty-five percent of their patients also experienced a temporary increase of at least 0.2 ng/mL. Seventy-five percent of these patients experienced a PSA rise between 0.3 and 3.4 ng/ mL. In this study, the mean time to rise was 24.8 months. (Read ‘Dose remained the most significant predictor…’…)

Nowadays more and more men and women experience different diseases connected with their sexual life. One of the most widespread men’s problems is impotence or erectile dysfunction that is the inability to achieve or maintain an erection to have sex. It affects one in ten men and in may be caused by different reasons, both psychological and physical.

In most cases several physical problems affect the blood supply. Though, there’s a complex relationship between the psychological and physical sexual function aspects. There are several medical conditions that may cause impotence, such as: hormone imbalances, diabetes, Parkinson’s disease, multiple sclerosis. Psy (Read ‘Men and Women, Health Problems Sexual Life.’…)

The Joint analysis, which included the researchers from Agency of Protection of Health (HPA) West Midlands and is published in journal Sexual Sent Infections (IIT), is shown increasing factor sexual infection on folk over 45 years west Midlands.

The Analysis studied the episodes to infections between 1996 and 2003 and found upwards direction in row visit on 45s visitting Medicine Genitourinary (the GLUE) of the clinic for Sexual Sent Infection (IIT) west Midlands. In 1996, this age group included 3.9% all clinical visit; to 2003, this rose before 4.5%.

The Analysis looked at local given for a period of 1996-2003 and focused on five IIT - chlamydia, shingles sexual, warts sexual, gonorrhoea and syphilis. (Read ‘Sexually Transmitted Infections Among Over 45s On The Increase’…)

Approves Third Pill for Weekness, Intensifying Competitions on Market Billion-Dollar

The Third pill to address weekness was approved for selling in United Staffs for Friday, intensifying competition in billionth dollar of the tenderloin market medicine. The New pill will is sold under name Cialis. This joins to Viagra, spoken medicine, which continued the market in 1998, and Levitra, which was approved earlier this year Food and Administration Medicine.

All three medicines act in enzyme, which helps prompt and support the buildings weakenning muscles in penis and blood ship. Duration and begin actions medicine - another, however, with each pills. (Read ‘FDA Approves Third Pill For Impotence’…)

Health Canada advises men who take the drugs such as Viagra, Levitra and Cialis to consult their doctors and look for urgent medical help if they have sudden problems with vision such as vision loss or blurred vision or any other while they are taking these medicines. Viagra, Levitra and Cialis are medications that used to treat erectile dysfunction and impotence in men.

In 2005 the Journal of Neuro-Ophthalmology published an article where fourteen cases of non arteritic ischemic optic neuropathy (NAION) happened in patients who used Viagra were discussed. (Read ‘Health Canada advises men…’…)

Pfizer Starts Campaign Against Illegal Generic and Fake Viagra Merchants and Viagra-Related Spam Senders.

Unlawful and unlicensed internet “pharmacies” mislead purchasers, intrude on customers’ privacy and pose financial and public health risks.

These days Pfizer, the Viagra (sildenafil citrate) manufacturer, has announced that the company starts to take lawful action against several unlawful internet “pharmacies” and work with law enforcement agencies to stop sales of fake Viagra and illegitimate “generic” ED medicine versions of Pfizer. A (Read ‘Viagra (sildenafil citrate) manufacturer’…)

After just half a year, Cialis (tadalafil), the most recent oral impotence treatment on the market in the United States, is challenging Viagra (sildenafil) for share of the erectile dysfunction market. Now Cialis leads in latest medication initiations by urologists. ICOS Corporation is marketing Cialis (tadalafil) via Lilly ICOS LLC, that is a joint venture among ICOS Corporation /Nasdaq: ICOS/ and Eli Lilly and Company /NYSE: LLY/. Cialis is the only oral medication for ED which improves erectile function of most men up to thirty six hours. (Read ‘Cialis Leads in Changing Prescriptions’…)

The first forthcoming trial purposely designed in order to estimate erectile function in patients with erectile dysfunction (ED) and with dyslipidemia was recently conducted. Its results show that LEVITRA (vardenafil), that is used to treat ED, considerably improves the ability of a man with these problems to reach and sustain an erection in order to have successful intercourse. These results were presented at the annual fall Meeting of the Sexual Medicine Society of North America (SMSNA) that was taken place in Chicago.

The placebo-controlled, randomized, double-blind study is the first investigation to evaluate the efficacy and safety of a phosphodiesterase type 5 inhibitor in a group of men with erectile dysfunction and dyslipidemia. (Read ‘Erectile dysfunction (ED), results LEVITRA (vardenafil)’…)